<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03954470</url>
  </required_header>
  <id_info>
    <org_study_id>API/2017/87</org_study_id>
    <nct_id>NCT03954470</nct_id>
  </id_info>
  <brief_title>Factors Influencing Risk of Progression of Chronic Kidney Disease</brief_title>
  <acronym>FAIR-PROGRESS</acronym>
  <official_title>Factors Influencing Risk of Progression of Chronic Kidney Disease in Patients With Severe Renal Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to identify typical patterns of renal function evolution in patients
      with stage 4 chronic kidney disease, regularly followed in nephrology consultation and
      included in a French cohort.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 9, 2012</start_date>
  <completion_date type="Actual">December 31, 2018</completion_date>
  <primary_completion_date type="Actual">December 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evolution of estimated Glomerular Filtration Rate (GFR) according to MDRD equation (modification of diet in renal disease) at each visit</measure>
    <time_frame>up to 3 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Time between inclusion and occurrence of the &quot;progression&quot; event</measure>
    <time_frame>up to 3 years</time_frame>
    <description>progression: initiation of an extra-renal purification technique or reduction of GFR of at least 5 mL / min / 1.73m2 compared to inclusion in FAIR-PROGRESS</description>
  </primary_outcome>
  <enrollment type="Actual">1300</enrollment>
  <condition>Chronic Kidney Disease stage4</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adult population with chronic renal failure, before replacement therapy, followed in 9
        nephrology departments of Bourgogne Franche-Comté.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients meeting the inclusion criteria of the ND-CRIS cohort (long-term follow-up in
             one of the centers participating in the research, with a GFR &lt;60mL/min /1.73m2)

          -  Patients included in the ND-CRIS cohort on the date when the estimate of their GFR is
             strictly less than 30mL/min/1.73m2 and greater than or equal to 15mL/min/1.73m2 (MDRD
             equation).

        Patients should have at least two measurements of GFR &lt;30mL/min/1.73m2 to be included, at
        least one of them greater than or equal to 15mL/min/1.73m2. The date of the first GFR
        &lt;30mL/min/ 1.73m2 will be considered as the date of origin.

        Exclusion Criteria:

          -  Patients with GFR ≥30mL / min / 1.73m2 or &lt;15mL / min / 1.73m2

          -  Patients who do not meet the inclusion criteria of ND-CRIS cohort (dialysis patients,
             transplant patients, unfollowed patients)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Besançon</name>
      <address>
        <city>Besançon</city>
        <zip>25000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 13, 2019</study_first_submitted>
  <study_first_submitted_qc>May 16, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 17, 2019</study_first_posted>
  <last_update_submitted>May 16, 2019</last_update_submitted>
  <last_update_submitted_qc>May 16, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 17, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

